American Diabetes Association Scientific Sessions

Healio brings you the highlights from the American Diabetes Association Scientific Sessions. Refer back to this page often for the latest news from ADA, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News

DEVOTE: Insulin degludec demonstrates CV safety, reduced risk for severe hypoglycemia

June 21, 2017
SAN DIEGO — In the DEVOTE cardiovascular outcomes trial, insulin degludec was noninferior to insulin glargine for the primary endpoint of major…
Meeting News

Top takeaways from American Diabetes Association Scientific Sessions

June 16, 2017
The American Diabetes Association 77th Scientific Sessions recently wrapped in San Diego. Topics discussed included lowering cardiovascular risks in…
Meeting News

Hybrid closed-loop system viable for children with type 1 diabetes

June 15, 2017
SAN DIEGO — A hybrid-closed loop insulin control system used in children with type 1 diabetes was safe for both overall and overnight control…
Meeting News

SMBG fails to improve glycemic control in adults with type 2 diabetes

June 15, 2017
SAN DIEGO — Self-monitoring of blood glucose with or without tailored messages did not significantly improve glycemic control compared with no…
Meeting News

Oral, subcutaneous insulin similar in efficacy

June 15, 2017
SAN DIEGO — Adults with type 2 diabetes assigned to once-daily oral insulin achieve similar HbA1c and fasting plasma glucose levels compared…
Meeting News

Long-term metformin therapy reduces CVD risk in type 1 diabetes

June 15, 2017
SAN DIEGO — Middle-aged adults with long-standing type 1 diabetes at high risk for cardiovascular disease who added metformin to insulin…
Meeting News

Oral insulin therapy fails to prevent type 1 diabetes, but some see disease delay

June 15, 2017
SAN DIEGO — In adults with two or more antibodies predicting the development of type 1 diabetes, treatment with daily oral insulin therapy did…
Meeting News

Glucagon receptor blockade may reduce insulin dose requirement in type 1 diabetes

June 14, 2017
SAN DIEGO — A single dose of an investigational agent that blocks glucagon receptors can lower the amount of insulin needed and improve glucose…
Meeting News

CVD-REAL: SGLT2 inhibitors benefit patients with diabetes, irrespective of CV history

June 14, 2017
SAN DIEGO — Treatment with an SGLT2 inhibitor was associated with lower rates of death and heart failure compared with other glucose-lowering…
Meeting News

Nasal glucagon viable option for type 1 diabetes

June 14, 2017
SAN DIEGO — Moderate to severe hypoglycemic episodes in adults with type 1 diabetes may effectively be treated with nasal glucagon, and…

Meeting Calendar

American Diabetes Association Scientific Sessions

June 22, 2018 - June 26, 2018

Advertisement
Advertisement